Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update - September 2018

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for September 2018 (PDF).

This issue advises that valproate medicines must not be used in women of childbearing potential unless the Pregnancy Prevention Programme is in place. The reminder contains links resources and previous drug safety articles.

Also this month, the summary of letters to healthcare professionals includes a copy of information sent regarding the new contraindications and liver monitoring requirements for ulipristal acetate (Esmya®).

Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.

Share 'Drug Safety Update - September 2018' on Email Share 'Drug Safety Update - September 2018' on Delicious Share 'Drug Safety Update - September 2018' on Digg Share 'Drug Safety Update - September 2018' on Facebook Share 'Drug Safety Update - September 2018' on reddit Share 'Drug Safety Update - September 2018' on StumbleUpon Share 'Drug Safety Update - September 2018' on Twitter

atomic-wealth

No Comments to “Drug Safety Update - September 2018”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer